Clinical trial
Randomized, Double-blind, Placebo-controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients With Congestive Heart Failure
NCT01837082 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Placebo-controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients With Congestive Heart Failure
- Lead sponsor
- University of Ulm
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 30, 2013
- Completion date
- December 31, 2015
- Enrollment
- 18 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, heart failure, iron deficiency